• Users Online: 91
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2022  |  Volume : 39  |  Issue : 1  |  Page : 40-47

The effect of risk factors on the clinical course and treatment of older patients with coronavirus disease 2019


1 Department of Neurology, Gulhane Training and Research Hospital, University of Health Science, Ankara, Turkey
2 Department of Neurology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey
3 Department of Family Medicine, Gulhane School of Medicine, University of Health Science, Ankara, Turkey
4 Department of History of Medicine and Deantology, Gulhane School of Medicine, University of Health Science, Ankara, Turkey
5 Department of Infectious Disease, University of Health Science, Gulhane School of Medicine, Ankara, Turkey
6 Department of Chest Diseases, Gulhane School of Medicine, University of Health Science, Ankara, Turkey

Correspondence Address:
Ulkuhan Duzgun
Department of Neurology, University of Health Science, Gulhane Training and Research Hospital, Ankara
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/nsn.nsn_114_21

Rights and Permissions

Introduction: Coronavirus disease 2019 (COVID-19) is known to have higher morbidity and mortality rates, parallel to the increased risk factors in the elderly. We aimed to define the risk factors related to mortality and morbidity in older patients hospitalized with COVID-19 disease in this study. Materials and Methods: This retrospective cross-sectional study included patients aged ≥65 years who were hospitalized with a confirmed diagnosis of COVID-19. We analyzed their demographic data, clinical findings, comorbidities, laboratory and radiologic findings, treatment protocols, and outcomes. Results: A total of 58 patients were included in the study. A total of eight (13.8%) patients died during the clinical follow-up and treatment, and 50 (86.2%) patients were discharged. The most common comorbidities among all patients were hypertension (HT) (69%) and diabetes mellitus (39.7%). The most common symptoms include fever (51.7%), cough (44.8%), and dyspnea (43.1%), and the most common neurologic findings were headache (27.6%) and impaired consciousness (27.6%). Intensive care unit admission was significantly higher among patients with comorbidities of HT, cerebrovascular disease, atrial fibrillation (AF), and chronic obstructive pulmonary disease. The rate of death was significantly higher in patients with a history of smoking, cerebrovascular disease, AF, and HT. Although there was a statistically significant positive correlation between the death rate and leukocyte, neutrophil, C-reactive protein, lactate dehydrogenase, D-dimer, interleukin-6, and procalcitonin levels, a negative correlation was observed in lymphocyte levels. Conclusion: Age-related comorbid conditions, especially HT, cerebrovascular disease, and AF, caused increased morbidity and mortality rates in older patients with COVID-19.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed396    
    Printed14    
    Emailed0    
    PDF Downloaded76    
    Comments [Add]    

Recommend this journal